Trials / Unknown
UnknownNCT03800628
Resource Availability Following Critical Illness
Perception of Quality of Life and Resource Availability After Surviving Critical Illness
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Walden University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this qualitative study is to explore the vital issues in recovery of QOL from the perspective of survivors of critical illness and understand these patients' views on rehabilitative services in the United States (U.S.). The theoretical framework for this study is Max Weber's Rational Choice Theory (RCT). The research questions will focus on understanding post-ICU QOL and the patients' experience with rehabilitative services following critical illness. A phenomenological study design is being employed, using semi-structured individual interviews with critical illness survivors. Data from the interviews will be coded for thematic analysis. The implications for social change include defining the meaning of QOL for an ICU survivor and improving healthcare policies for the therapies necessary to return survivors to a life worth living.
Detailed description
The purpose of this qualitative study is to understand the patient perception of QOL after surviving critical illness and how survivors can help illuminate gaps in current health policies to provide better recovery resources for this growing population. The central research questions are: RQ1: What are the issues important to preserve quality of life from the perspective of critical illness survivors? RQ2: How do survivors of critical illness describe rehabilitative services after discharge?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | qualitative study | semi-structured interviews |
Timeline
- Start date
- 2018-12-07
- Primary completion
- 2019-06-30
- Completion
- 2019-08-30
- First posted
- 2019-01-11
- Last updated
- 2019-01-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03800628. Inclusion in this directory is not an endorsement.